Display Settings:

Format

Send to:

Choose Destination
Int Arch Allergy Immunol. 2010;153(2):109-20. doi: 10.1159/000312628. Epub 2010 Apr 21.

Macrophage activation syndrome in autoimmune disease.

Author information

  • 1Division of Rheumatology, Allergy and Clinical Immunology, University of California, Davis, CA 95616, USA. megershwin@ucdavis.edu

Abstract

Macrophage activation syndrome (MAS) is a phenomenon characterized by cytopenia, organ dysfunction, and coagulopathy associated with an inappropriate activation of macrophages. Current diagnostic criteria are imprecise, but the syndrome is now recognized as a form of hemophagocytic lymphohistiocytosis that is characteristically associated with autoimmune diatheses. The diagnosis of incipient MAS in patients with autoimmune disease requires a high index of suspicion, as several characteristics of the disorder may be present in the underlying condition or infectious complications associated with the treatment thereof. Proposed treatment regimens include aggressive approaches that require validation in future controlled studies. This review discusses the major aspects of the pathophysiology, diagnosis, and management of MAS with a focus on the association with autoimmune disease.

Copyright © 2010 S. Karger AG, Basel.

PMID:
20407267
[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for S. Karger AG, Basel, Switzerland
    Loading ...
    Write to the Help Desk